Mekinist .5 mg/1 (Trametinib TABLET, FILM COATED) .5 mg/1

Mekinist (trametinib) is a prescription medication used to treat certain types of cancer. This oral tablet is designed to target specific proteins involved in cancer cell growth.

Strength

.5 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE (0078-1105-15)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mekinist is primarily used in the treatment of advanced or metastatic melanoma, a type of skin cancer. It may also be used in combination with other cancer therapies to target specific genetic mutations. Patients often ask, 'What is trametinib used for?' and the answer involves its role in managing cancers with specific genetic markers.

Side Effects

Common effects of Mekinist may include skin-related issues such as rash or acne, as well as fatigue and diarrhea. Some patients may experience changes in blood pressure or blood sugar levels. It's important to discuss any persistent or severe effects with a healthcare provider.

Precautions & Warnings

Mekinist should be handled with care, stored at room temperature, and kept away from children. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular monitoring may be necessary to manage potential side effects.

Avoid Interactions

Mekinist may interact with other medications, including those that affect the liver's ability to metabolize drugs. It is important to inform healthcare providers about all medications, including over-the-counter drugs and supplements, to avoid potential interactions.

References

Frequently Asked Questions

Mekinist is used to treat certain types of cancer, particularly advanced or metastatic melanoma with specific genetic mutations.

Mekinist is taken orally, typically once daily, with or without food. Follow the specific instructions provided by your healthcare provider.

Common side effects may include skin rash, fatigue, diarrhea, and changes in blood pressure or blood sugar levels.

Mekinist may interact with other medications, so it's important to discuss all current medications with your healthcare provider.

Mekinist should be stored at room temperature, away from moisture and heat, and kept out of reach of children.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.